Harbin Pharmaceutical Group, a Chinese partially state-owned pharmaceutical manufacturer, agreed to acquire GNC Holdings, a provider of health and nutrition-related products, including vitamins, supplements, minerals, herbs, sports nutrition, diet, and energy products, for $760m.